G6PD and breast carcinoma: Examining clonogenic potential under metabolic stress, the dual pharmacological inhibition synergistically and dramatically suppressed the clonogenic potential of breast cancer cells (Fig 6C); although clinically available, DHEA is an uncompetitive G6PD inhibitor.